A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System

June 17, 2016 updated by: DePuy International

A Prospective, Non-Comparative Multi Centre Study to Evaluate the Clinical Performance of the DePuy Press Fit Condylar (P.F.C.) Sigma Rotating Platform High Flexion Knee.

The purpose of this study is to evaluate if the P.F.C. Sigma RPF knee accommodates functional stability with a post-operative passive range of motion of greater than 125° of flexion and to demonstrate that the range of motion does not compromise the longevity of the implant.

Study Overview

Status

Terminated

Conditions

Detailed Description

Primary endpoint is to demonstrate that 90% of patients have a functionally stable knee that can achieve post operative range of motion of 125 degrees or greater.

The secondary endpoint is to investigate the survivorship of the P.F.C. Sigma RP-F knee at 1, 2, 3, 5, 10, 15 and 20 years

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maharashtra
      • Mumbai, Maharashtra, India, 400 054
        • The Nook, 51/B SV Road
    • Kobe
      • Chuoku, Kobe, Japan
        • Kobe University Graduate School Of Medicine, 7-5-1 Kusundki- cho
    • Seoul
      • Dongdaemun Gu, Seoul, Korea, Republic of
        • Kyunghee University Hospital, 1 HoegiDong
    • Wellington
      • Newtown, Wellington, New Zealand
        • Wellington School Of Medicine Surgical Research Trust, Main Street
      • Tan Tock Seng, Singapore, 308433
        • Tan Tock Seng Hospital, No 11 Jalan
      • Bangkok, Thailand, 10700
        • Sirriraj Hospital, Mahidol University
      • Nottingham, United Kingdom, NG5 1PB
        • Nottingham City Hospital, Hucknell Road
      • York, United Kingdom
        • Clifton Park NHS Treatment Centre, Blue Beck Drive, Shipton Road

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female subjects, aged between 45 and 75 years inclusive.
  • Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • Subjects who are able to achieve a pre-operative passive range of motion of equal to or greater than 110º.
  • Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
  • Subjects who present with idiopathic osteoarthritis that in the opinion of the clinical investigator requires a primary total knee arthroplasty.
  • Subjects who in the opinion of the Clinical Investigator are considered to be suitable for treatment with the P.F.C.® Sigma RPF knee, according to the indications specified in the package insert leaflet.

Exclusion Criteria:

  • Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study.
  • Women who are pregnant.
  • Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.
  • Subjects who have participated in a clinical study with an investigational product in the last month (30 days).
  • Subjects who are currently involved in any personal injury litigation claims.
  • Subjects with a known history of poor compliance to medical treatment.
  • Subjects who have a pre-operative limb deformity of equal to or greater than 10° varus or 15° valgus as defined using the anatomical axis.
  • Subjects who have morbid obesity i.e. BMI ≥40.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: P.F.C. Sigma RP-F Total Knee Replacement
An orthopaedic implant for total knee replacement with a mobile-bearing and a high flexion design
An orthopaedic implant for total knee replacement with a mobile-bearing and a high flexion design

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with a functionally stable knee that can achieve post-operative range of motion of 125° or greater.
Time Frame: 1 year
Proportion of cases that have a functionally stable knee (Q10 of Oxford Knee Score is 'rarely/never' or 'sometimes, or just at first'), AND can achieve 1-year post-op passive range of motion of 125 degrees or greater.
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Survivorship of the P.F.C.® Sigma RPF knee at 1, 2, 3, 5, 10, 15 and 20 years.
Time Frame: 1, 2, 3 and 5 years
1, 2, 3 and 5 years
American Knee Society Change from Baseline Knee and Function Scores at 1, 2, 3, 5, 10, 15 and 20 years
Time Frame: 1, 2, 3 and 5 years
1, 2, 3 and 5 years
Radiographic assessments at 1, 2, 3, 5, 10, 15 and 20 years
Time Frame: 1, 2, 3 and 5 years
1, 2, 3 and 5 years
Oxford Knee Score at 1, 2, 3, 5, 10, 15 and 20 years
Time Frame: 1, 2, 3 and 5 years
1, 2, 3 and 5 years
Patellar Score at 1, 2, 3, 5, 10, 15 and 20 years
Time Frame: 1, 2, 3 and 5 years
1, 2, 3 and 5 years
SF-12 1, 2, 3, 5, 10, 15 and 20 years
Time Frame: 1, 2, 3 and 5 years
1, 2, 3 and 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2004

Primary Completion (ACTUAL)

February 1, 2010

Study Completion (ACTUAL)

May 1, 2015

Study Registration Dates

First Submitted

September 26, 2008

First Submitted That Met QC Criteria

September 26, 2008

First Posted (ESTIMATE)

September 29, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

June 20, 2016

Last Update Submitted That Met QC Criteria

June 17, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on P.F.C. Sigma RP-F Total Knee Replacement

Subscribe